11 December 2024
Professor Kjesten Wiig has been appointed Director of the Malaghan Institute of Medical Research at the organisation’s AGM today, as Professor Graham Le Gros continues in a leadership capacity as Deputy Chair of the Trust Board and advisor to the new Director.
Chair Sir Paul Collins says the Trust Board is delighted to appoint such a capable and well-respected leader as Director, whose time at the Malaghan has proven her readiness, ambition and vision for the role.
“She has big shoes to fill after Graham’s extraordinary tenure, but she’s poised to build on Graham’s legacy and forge her own,” he says.
Prof Wiig has held senior leadership roles at the Malaghan Institute since 2022 and was appointed Deputy Director in early 2024 with a view to transitioning into the director role. A neuroscientist by training, Prof Wiig’s career has spanned senior leadership roles in academia, industry and government, all with a focus on advancing science and innovation.
She says she is passionate about progressing research that will positively impact on people’s health and ultimately save lives.
“Graham has built an amazing organisation that I feel privileged to lead, bringing considerable learnings from my time spent in ambitious, US-based drug discovery companies as well as central government here in New Zealand to the role.”
Prof Le Gros says he is ready to hand over the baton to Prof Wiig after 30 years at the helm.
“This is not farewell – I’m not going away, but it is time to transition to a new leadership team, with Kjesten ably supported by Mike Zablocki as General Manager and our senior science and support leaders. This change takes the Malaghan Institute into a new era as we continue to be ambitious about what can be achieved here in New Zealand for the benefit of global health – tackling diseases that affect us all.”
Prof Wiig’s appointment to Director and Prof Le Gros’ appointment to Deputy Chair will be effective from 1 January 2025.
“As Chair I’m delighted we can retain Graham in this important role as my deputy moving forward and in an advisory role to the new director through this change,” says Sir Paul.
“This will continue be a strong and seamless transition and, alongside a refreshed and strengthened governance team, places the Malaghan Institute in an excellent position for the future.”
Related articles
Kjesten Wiig appointed Director of Malaghan Institute as Graham Le Gros steps into new role
11 December 2024
Fast Start grant to explore and establish next generation RNA technology
7 October 2024
Malaghan scientists appointed in leadership roles in New Zealand's RNA Platform
31 May 2024
A revolution in cancer care is near; here’s what’s needed to make it happen
9 May 2024
Malaghan Institute and BioOra deliver automated manufacturing to scale up CAR T-cell cancer therapy in NZ
16 August 2023
Investment in science will boost New Zealand’s resilience and prosperity
18 May 2023